10X Genomics
TXG51
$15.320.00%$0.00
TXG51
$15.32
0.00%| Key Stats | |
|---|---|
| Open | $15.36 |
| Prev. Close | $15.37 |
| EPS | -2.03 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 14.94 | 15.71 |
| 52 Week Range | 15.28 | 57.90 |
| Ratios | |
|---|---|
| EPS | -2.03 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.83% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
TXG-
US Healthcare Sector-
US Market-
warning
TXG / Market
TXG lose to the US Market which returned -0.58% over the last twenty four hours.warning
TXG / Healthcare Sector
TXG lose to the US Healthcare sector which returned 2.19% over the last twenty four hours.10X Genomics (TXG) Statistics
Keep an eye on 10X Genomics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has 10X Genomics (TXG) stock's performance compared to its sector and the market over the past year?
Over the past year, 10X Genomics (TXG) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 37.77%, 10X Genomics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 74.16%, it has fallen short of the market average. This comparison highlights 10X Genomics 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of 10X Genomics (TXG) stock?
The PE ratio for 10X Genomics (TXG) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of 10X Genomics (TXG) stock?
The Earnings Per Share (EPS) for 10X Genomics (TXG), calculated on a diluted basis, is -$2.03. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of 10X Genomics (TXG) stock?
The operating margin for 10X Genomics (TXG) is -27.26%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of 10X Genomics (TXG) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of 10X Genomics (TXG) is -$146.28M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does 10X Genomics (TXG) have?
10X Genomics (TXG) has a total debt of $89.48M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$290.34M.